Shanghai, China

Yingfeng Li

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Shanghaitech University. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yingfeng Li: Innovator in Programmable Amyloid Materials

Introduction: Yingfeng Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of material science, particularly through his innovative work with amyloid-based materials. His research focuses on creating materials with integrated genetically programmable functionalities.

Latest Patents: Yingfeng Li holds a patent for an "Amyloid-based fundamental building material with integrated genetically programmable functionality." This patent describes a material fabrication method that involves fabricating a structure from a programmable amyloid material (PAM) ink. The process includes stabilizing an amyloid monomer in a liquid solvent and triggering polymerization to stabilize the structure.

Career Highlights: Yingfeng Li is affiliated with ShanghaiTech University, where he continues to advance his research in material science. His work has garnered attention for its potential applications in various fields, including biotechnology and materials engineering.

Collaborations: Yingfeng Li has collaborated with notable colleagues, including Chao Zhong and Ke Zhao Li. These partnerships have further enriched his research and contributed to the development of innovative materials.

Conclusion: Yingfeng Li's contributions to the field of programmable amyloid materials highlight his role as a leading inventor in material science. His innovative approaches and collaborations continue to pave the way for advancements in this exciting area of research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…